Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Abhinav Shashank, Cody Simmons, CEO at DermaSensor.
What you’ll get out of this episode:
- Cody Simmons' Background: Cody discusses his journey from a biomaterials lab at Stanford and roles at Genentech, leading to his involvement with DermaSensor, a health tech startup.
- DermaSensor's Evolution: Founded in 2009, DermaSensor was initially a research-focused virtual startup. Cody joined in 2016, transforming it into a fully-fledged company, leading to the recent FDA clearance.
- FDA Clearance Milestone: DermaSensor's device, which has transitioned from a 30-pound machine to a portable size, received FDA clearance, marking a significant achievement for the company and a relief for the team.
- Impact on Primary Care: The device provides primary care physicians (PCPs) with dermatologist-level skin cancer triage capabilities, addressing a longstanding need for improved skin cancer assessment tools in primary care.
- Use of AI in DermaSensor: DermaSensor employs AI for lesion assessment, using a locked algorithm to ensure accuracy and adherence to FDA requirements. The technology allows for a standardized analysis, offering a real-time quantitative result for skin cancer risk.